About
Active Regenera
Regenera Activa is the worldwide distributor of the Rigenera® technology and developer of the AMT® procedure, specializing in Dermatology and Orthopaedics.
We are the official partners of the Regenera Activa company and the distributors of the Rigenera® technology and AMT® procedure in Romania.
The Rigenera® technology
The original technology was created to obtain autologous micrograft suspensions from the disaggregation of solid tissue biopsies. It encompasses different medical devices designed to meet various needs in the Dermatology and Orthopaedics lines.
What is AMT®?
Autologous Micrografting Technology (AMT®) is a simple and highly safe procedure that transfers the body's regenerative potential to affected areas. Class I and II medical devices are used to obtain a micrograft solution from small biopsies. This solution contains a variety of cell types, such as chondroprogenitor cells, including a concentration of growth factors and extracellular matrix components. These cells work to regenerate normal function in the affected tissues. Due to the minimal manipulation of patient-derived biopsies, AMT® is considered an autologous and minimally invasive treatment.
Minimally Invasive
One surgical time
30 min procedures
Protocols
Regenera Activa uses advanced micrograft technology with tailored protocols for each medical line. This allows us to effectively address various patient needs and conditions with specialized devices.
Follow us on Instagram
Str. Oasului 28, ground floor, apartment 1, 075100
Otopeni, Ilfov, Romania
+ 40 756 020 460
+ 34 674 62 09 40
